Table 4. Comparison of incidence of adverse reactions.
| Comparator | Intervention [odds ratios (95% CI)] | |||||||
|---|---|---|---|---|---|---|---|---|
| BXS | HLS | HQS | HPS | LPS | WFS | WSS | JHS | |
| HLS | −1.293* (−3.244, 0.553) |
|||||||
| HQS | 0.418 (−0.870, 1.803) |
1.722 (−0.403, 3.985) |
||||||
| HPS | −0.011 (−2.653, 3.635) |
1.247 (−1.718, 5.208) |
−0.431 (−3.309, 3.291) |
|||||
| LPS | 0.072 (−1.749, 2.396) |
1.377 (−1.033, 4.220) |
−0.327 (−2.552, 2.173) |
0.118 (−3.849, 3.486) |
||||
| WFS | −0.179* (−1.192, 0.900) |
1.102 (−0.805, 3.145) |
−0.597* (−2.077 0.816) |
−0.107 (−3.834, 2.460) |
−0.263 (−2.578, 1.704) |
|||
| WSS | 0.0438 (−0.990, 1.106) |
1.322 (−0.595, 3.351) |
−0.376 (−1.891, 1.038) |
0.111 (−3.678, 2.698) |
−0.034 (−2.398, 1.907) |
0.240 (−0.960, 1.330) |
||
| JHS | −0.505* (−1.277, 0.278) |
0.798 (−1.027, 2.653) |
−0.918* (−2.261 0.318) |
−0.451 (−4.101, 2.117) |
−0.560 (−2.799, 1.204) |
−0.313* (−1.312, 0.531) |
−0.550* (−1.511, 0.357) |
|
| SQ | −0.953* (−1.627, −0.298) |
0.322 (−1.396, 2.156) |
−1.370* (−2.632, −0.203) |
−0.904 (−4.589, 1.591) |
−0.772* (−1.640, −0.018) |
0.772 (0.018, 1.640) |
−1.004* (−1.834, −0.219) |
−0.459* (−0.890, −0.037) |
* represents statistically significant superiority/inferiority of the intervention over the comparator. BXS, Banxiaxiexin decoction; HLS, Huanglian Wendan decoction; HQS, Huangqi Jianzhong decoction; HPS, Huopu Xialing decoction; LPS, Lianpuyin; WFS, Weifuchun; WSS, Weisu granule; JHS, Jinghua Weikang; SQ, standard quadruple.